Physician profile
Audrey Ahuero
NPI 1942360516
$1,783.29
in general payments reported to CMS, 2019-2025
15 companies · $54.44 in 2025
The $54.44 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $23.52 · 2021: $322 · 2022: $371 · 2023: $386 · 2024: $428 · 2025: $54.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $869.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $868.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $352.38 | 2021-2023 | Tepezza |
| Galderma Laboratories, L.P. | $280.83 | 2019-2025 | |
| Tarsus Pharmaceuticals, INC. | $257.18 | 2024-2025 | Xdemvy |
| Axogen | $149.03 | 2023 | Avance Nerve Graft |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $123.99 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $119.13 | 2022-2024 | Vyzulta |
| Amgen INC. | $118.89 | 2024 | Tepezza |
| Eyevance Pharmaceuticals LLC | $110.26 | 2021-2022 | |
| Abbvie INC. | $79.90 | 2023-2024 | |
| Shire North American Group INC | $64.34 | 2019 | |
| Zimmer Biomet Holdings, INC. | $35.41 | 2019 | |
| Biotissue Holdings INC. | $29.73 | 2022 | |
| Allergan, INC. | $24.82 | 2022 | |
| Novartis Pharmaceuticals Corporation | $22.27 | 2021 | |
| Alcon Vision LLC | $15.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audrey Ahuero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.